SEC Form 4 · accession 0001276038-26-000006
COLLEGIUM PHARMACEUTICAL, INC · COLL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gino Santini
Director
Period of report
Jun 8, 2026
Accepted (ET)
Jun 10, 2026 · 4:10 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001267565
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 8, 2026 | M | 8,700 | $16.49 | A | 112,483 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Purchase)F1 | $16.49 | Jun 8, 2026 | M | 8,700 | D | — | Jun 9, 2026 | Common Stock | 8,700 | 0 | D |
Explanation of responses
- F1The option is fully vested and exercisable.